PCP
TEVA icon

Proficio Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Proficio Capital Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-365
Closed -$3K – 1374
2019
Q2 		$3K Sell
365
-421
-54% -$5.08K ﹤0.01% 1438
2019
Q1 		$12K Sell
786
-76
-9% -$1.34K ﹤0.01% 834
2018
Q4 		$13K Sell
862
-49
-5% -$1K 0.01% 672
2018
Q3 		$20K Buy
911
+8
+0.9% +$186 0.01% 601
2018
Q2 		$22K Buy
903
+114
+14% +$2.33K 0.01% 581
2018
Q1 		$13K Sell
789
-153
-16% -$2.99K ﹤0.01% 739
2017
Q4 		$18K Buy
942
+862
+1,078% +$13K 0.01% 624
2017
Q3 		$1K Sell
80
-69
-46% -$1.55K ﹤0.01% 1215
2017
Q2 		$5K Buy
149
+53
+55% +$1.64K ﹤0.01% 972
2017
Q1 		$3K Sell
96
-237
-71% -$8.09K ﹤0.01% 1091
2016
Q4 		$12K Sell
333
-295
-47% -$11.8K 0.01% 570
2016
Q3 		$29K Sell
628
-93
-13% -$4.85K 0.02% 365
2016
Q2 		$40K Buy
721
+500
+226% +$26.6K 0.03% 303
2016
Q1 		$12K Buy
221
+30
+16% +$1.76K 0.01% 391
2015
Q4 		$13K Buy
+191
New +$11.8K 0.01% 245

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Proficio Capital Partners's TEVA Position: Q3 2019 in Review

Proficio Capital Partners sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 365 shares — an estimated $3K sold.

Proficio Capital Partners first reported a position in TEVA in Q4 2015 and held it in 15 quarters. The position peaked at $40K in Q2 2016. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Proficio Capital Partners reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 365 Teva Pharmaceuticals shares in Q3 2019, an estimated $3K.
  • Proficio Capital Partners first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 15 quarters.
  • Proficio Capital Partners's Teva Pharmaceuticals position peaked at $40K in Q2 2016.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.